Development Technologies is trading at 9.12 as of the 24th of December 2024, a 45.92% increase since the beginning of the trading day. The stock's open price was 6.25. Development Technologies has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. The performance scores are derived for the period starting the 24th of November 2024 and ending today, the 24th of December 2024. Click here to learn more.
Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. Pegasus Pharmaceuticals Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida. Development Technologies operates under Shell Companies classification in the United States and is traded on OTC Exchange.. More on Development Technologies Corp
Our tools can tell you how much better you can do entering a position in Development Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Insider Screener Now
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Other Information on Investing in Development Pink Sheet
Development Technologies financial ratios help investors to determine whether Development Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Development with respect to the benefits of owning Development Technologies security.